7 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship
sponsored by Dignity Health, St. John's Hospital
The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research.
One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and device concepts into clinical application.
Goal: The overall goal of the program is to provide the clinical scientist (a physician) with the necessary scientific background that does not exist in today's curriculum. The program will enable the awardee to expedite scientific discovery to clinical application, ultimately benefitting the patient and society by providing science earlier and decreasing the developmental costs related to new devices and/or novel biologic therapies.
The program will cover the topics of:
• Basic science
• Preclinical science
• Clinical science and trial design
• Regulatory pathways (FDA) for IND (investigational new drug application) and IDE (investigational new device exemption)
The emphasis will be on biologics (stem cell therapy and genomics) and cardiovascular device development.
Objectives: The fellow will:
• Develop the skills and knowledge to take a scientific concept to the bedside
• Gain substantial knowledge about the steps in cardiovascular translational research
• Understand product development related to devices or biologics
• Learn about toxicology studies required on small and large animal models that serve for IND or IDE application
• Understand the statistical design and analysis required for toxicology studies, and phase I, II, and III clinical trials
• Learn about the regulatory pathways for and how to prepare an IND (Investigational Drug Application) and an IDE (Investigational Device Exemption)
• Understand fundraising, NIH grant application process, opportunities in the venture capital arena, and developing and maintaining relationships with industry
Eligibility: Applicants eligible for the award are those who:
• Have completed one year of previous interventional cardiology.
• Are members or are eligible to become a member of the ACC and ISCTR
• Will spend the duration of the Scholarship at an institution that has the ability to perform translational research (conducts both preclinical and clinical research) and can administer the curriculum found here:
The Award: The award will offer $60,000 of salary support to begin July 1, 2014 and run through June 30, 2015.
Funding Source: The ACCF is grateful to Dignity Health St. John’s Hospital for their financial support for this award.
Nomination Procedure: Criteria for selection includes qualifications, background, interests, and commitment of the applicant.
How to Apply: The submission site for applications will open this summer. Please stay tuned for more information.
Deadline: September 23, 2013
For more information: Email Julia Berman or call 800-253-4636, ext. 6648.
American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease
Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.
Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.
Preference for one award will be given to applicants focusing on disparities of care. Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities. Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical. In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.
Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.
Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:
• Scientific quality of the project;
• Relevance to the research focus as described above;
• Qualifications and commitment of the applicant; and
• The quality of the training environment.
Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:
• Will pursue clinical research training and experience directly involving patients or human subjects.
• Have had no more than two years of prior full-time research experience either in clinical or basic research.
• Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.
The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2014 and run through June 30, 2015.
Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.
American College of Cardiology Foundation/William F. Keating, Esq. Endowment Career Development Award
The purpose of the award is to recognize and provide financial support for research efforts by outstanding your cardiovascular scholars. This award is to encourage junior faculty in the early phases of their careers in the field of cardiology. The award will provide one junior faculty member with a year of research support. Preference will be given to applications focusing on hypertension and/or peripheral vascular disease.
1. Will hold rank of instructor or assistant professor at the time of the initiation of the award and have completed adult, pediatric, surgical cardiology fellowship training in a program approved by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association;
2. Are members or are eligible to become a member of the American College of Cardiology (ACC);
3. Are no more than five years out of training;
4. Have the recommendation and agreement of their division chiefs and their chiefs' assurance that the awards' support will provide protected time for the applicants to pursue their research programs; and
5. Have an agreement with their institutions that the full amount of the award will be designated for the salary support.
The Award: The award will offer $70,000 salary support for one year of research to begin July 1, 2014 and run through June 30, 2015.
Funding Source: The ACC is grateful to the William F. Keating Endowment Fund for supporting this award.
Nomination Procedure: Criteria for selection includes scientific quality of the project, qualifications and commitment of the applicant, and support of the environment to foster the proposed project and applicant's success. Preference will be given to applications focusing on hypertension and/or peripheral vascular disease
Application Deadline: September 23, 2013
American College of Cardiology Foundation Young Investigator Awards Competition
The Young Investigator Awards competition encourages and recognizes young scientific investigators of promise, upon whom progress in the field of cardiology is dependent. A manuscript and abstract summarizing any problem that relates to cardiovascular disease whether it be in etiology, pathophysiology, diagnosis, or therapy.
Award Categories include the following:
1. ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology
2. Physiology, Pharmacology and Pathology
3. Clinical Investigations, Congenital Heart Disease and Cardiac Surgery
4.Cardiovascular Health Outcomes and Population Genetics
*Doctorate level nurses, physician assistants and clinical pharmacists in research are strongly encouraged to apply in this category
Eligibility: Physicians, scientists, medical students, and other healthcare providers currently in residency or fellowship programs, or are no more than three years out of training. PhD, PharmD or DNP candidates who are no more than three years out of training may also apply.
Note: Candidates will be eligible for this award up to four years after completion of training if more than three months of family or sick leave was taken during training or in the first three years after completion of training.
The Award: The first place winner for each category receives $2,000, second place winners receive $1,000; three honorable mentions in each category receive $500. Travel, hotel and meals up to $1,500 will be reimbursed for all 20 finalists to attend the YIA Competition at ACC.14 in Washington, DC.
Funding Source: Support for the ACCF/Herman K. Gold Young Investigator Awards in Molecular and Cellular Cardiology is provided by a grant from CV Path Institute and the family of Herman K. Gold.
Deadline: October 11, 2013
For more information: Email Kristin Robertson or call 800-253-4636, ext. 6390.
Summer 2013 - Mentored Clinical and Population Research Award
Application deadline: July 18, 2013
Award Activation Date: Jan. 1, 2014
Applications must be received no later than 5:00 p.m. CDT on the deadline date. The system will shut down at 5:00 p.m. CDT. Early submission is encouraged. Your institutional Grants Officer (GO) has the final responsibility of submitting your completed application to the American Heart Association. It is important that you check with your GO for his/her internal deadline.
To encourage early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community- and population-based activities.
This grant does not fund basic science or support senior researchers, but encourages mentoring of early career investigators.
Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts. Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. Studies using existing databases are also encouraged. Ancillary studies or a clearly defined sub-study of an ongoing clinical research study are also encouraged. There must, however, be clear justification that the proposal is a sub-study and not a piece of an already funded project.
• Healthcare professional with a masters or post-baccalaureate doctoral degree, including M.P.H., R.N., Pharm.D., M.D., D.O. or Ph.D.
• Interdisciplinary research teams are eligible.
Individuals are not eligible to be the principal investigator if they hold or have held:
• Certain NIH awards (such as RO1, R21, PO1)
• Certain AHA awards (BGIA, SDG, EIA, GIA); or
• An award equivalent to any of the above (an independent investigator award)
At the time of application, must have one of the following designations:
• U.S. citizen
• Permanent resident
• Pending permanent resident. Applicant must have applied for permanent residency and have filed form I-485 with the U.S. Citizenship and Immigration Services and have received authorization to legally remain in the U.S. (having filed an Application for Employment form I-765)
• E-3 Visa - specialty occupation worker
• H1-B Visa - temporary worker in a specialty occupation
• F-1 - Student Visa - temporary worker in a specialty occupation
• J-1 Visa - exchange visitor
• O-1 Visa - temporary worker with extraordinary abilities in the sciences
• TN Visa - NAFTA Professional
• G-4 Visa - family member of employee of international organizations and NATO
Awardee must meet American Heart Association citizenship criteria throughout the duration of the award.
Applicants are not required to reside in the United States for any period before applying for American Heart Association funding.
All applicants must identify a sponsor with an earned doctorate and a track record of high quality clinical investigation.
Annual Budget - National
Salary/Fringe: Up to $35,000 per year for salary and fringe of the principal investigator, collaborating investigator(s), and other participants with faculty appointments, including an allowance of up to $5,000 for the sponsor.
Institution may supplement stipend.
Indirect: 10 percent ($7,000)
Project Support: Project-related expenses, such as salaries of technical personnel, consultative services, supplies, equipment, computer/electronics, travel, volunteer subject costs, publication costs, within the following limits:
• Travel - $3,000 per year; international travel must have prior AHA approval.
• Computer purchase - National allows $5,000 for computer equipment/electronics.
Maximum Annual Award Amount: $77,000
Award Duration: Two years
Total Award Amount: $154,000
Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award
Submission Deadline: August 1, 2013
This award recognizes clinical and academic excellence in interventional vascular medicine and aims to stimulate continued commitment and dedication to both outstanding patient care and ongoing academic inquiry by young investigators. The winner will be announced and the award of a $10,000 scholarship will be presented in the Main Arena at TCT 2013.
Candidates for this award must be within five years of the start of their first fellowship or training period and specializing in interventional vascular medicine (interventional cardiology, endovascular medicine, or structural heart disease). Depending on the length of training, physicians in practice for one or two years may be eligible. Candidates may be from any country.
The Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award is sponsored by the Cardiovascular Research Foundation.
Criteria and Specifications
• Curriculum vitae
• One or more manuscripts (published, in press, or not yet submitted) that the applicant first-authored or one or more abstracts that the applicant first-authored, accompanied by:
◦ A three to five (3-5) page description of the project(s) and results
◦ At least one supporting letter from a project leader or mentor describing the importance of the project(s) and the applicant's role
• Two letters of recommendation from supervisors who have directly witnessed the applicant in the patient care setting attesting to clinical excellence
Deadline and Submission
All materials must be received on or before August 1, 2013. Materials received after August 1, 2013, will not be considered.
If you have any questions, please contact Denise Tong at 646-434-4501 or email@example.com
Lesbian Health Fund Research Grant Program
Application Receipt Deadlines: May 15 and October 15
The Lesbian Health Fund (LHF), a program of GLMA: Health Professionals Advancing LGBT Equality, was established in 1992 to define, study, and educate lesbians and their health care providers about lesbian health issues. LHF's mission is to improve the health of lesbians, other sexual minority women (SMW) and their families through research.
Research areas include:
Understanding social, family, and interpersonal influences as sources of stress or support
Eliminating inequalities in health care, including barriers to care, and improving quality of care and utilization rates
Development and testing of interventions to address mental and physical health needs of lesbians and other SMW, including but not limited to depression, identity related issues, eating disorders, substance abuse, obesity, cancer risks, cardiovascular disease and sexually transmitted infections
Sexual and reproductive health, including family & parenting issues
The deadlines for receipt of applications are May 15 and October 15.
Applications will be evaluated using the following 100 point scale:
Research design - 35 Points
Feasibility of accomplishing the project - 20 Points
Investigators' qualifications - 15 Points
Significance of the project to the lesbian community - 15 Points
Probability for Significat Future Funding - 15 points
In general, investigators are notified by mail approximately two months from the application deadline of its approval for funding. Grants range from $500 to $10,000. Grant award checks will be made to the primary institution identified on the application cover page. You may not begin your proposed research until you have received funding from LHF. Grant money is NOT awarded for completed research or for projects in progress.
Interim and final reports are to be submitted by the principal investigator. Upon completion of the project the investigator will be expected to present the results at either the annual Women in Medicine conference or the Annual Conference of GLMA. Within six months of project completion, the investigator is expected to submit a manuscript to a peer-reviewed journal for publication. A copy of the manuscript is to be sent simultaneously to the LHF Program Manager.
Grant Application Format
1. Cover Page
2. Abstract of the Project in 500 words or less (This should be a word document.)
3. Detailed Plan of Project:
maximum of six double spaced typed pages
includes hypotheses, goals and specific objectives of the project, a brief discussion of relevant background information, the relationship of the proposed project to other work already accomplished in the field, methods, sample size calculation with power analysis, and the significance of the project to the lesbian community
4. Itemized Budget:
supplies and expenses with justification (budget $750 for presentation at a conference)
support from other resources for this project for this fiscal year
total amount requested for the project from Lesbian Health Fund. The Lesbian Health Fund does not cover personnel costs (salary and benefits) for the Investigators or indirect institution costs.
5. Study protocol as approved or submitted to the Institutional Review Board of the investigator's institution if animals or humans are involved in the project
6. Curriculum Vitae of Principal Investigator (PI), Co-Investigator, and Faculty Supervisor if the PI is a student, and of any other project member mentioned by name in the application. If a faculty supervisor is involved, submit letter of support from that faculty member for supervising the project. Current LHF grantees may not participate in a new grant as PI or Co-Investigator until LHF receives their written Final Report.
7. Signed statement by the Investigator and, if applicable, by the Co-Investigator that:
all publications resulting from the research conducted from the award will acknowledge that the project was funded by the Lesbian Health Fund of the Gay and Lesbian Medical Association
the abstract of the grant will be publicized with the names of the Principal and Co-Investigator if the grant is funded
8. Evidence of the primary institution's tax exempt status
9. OPTIONAL: Articles or publications of direct relation to the proposed project.
Please number all pages and send 1 copy of each item as a email attachment to:
Amy Fielder, LHF Program Coordinator at firstname.lastname@example.org
Questions? Email email@example.com or call 202-600-8037 ext 303.